Sequential Therapy in Multiple Myeloma Guided by MRD Assessments

NCT05231629 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

300

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: Dara-VRd intensification, Dara-R maintenance
DRUG: AHCT intensification, Dara-R maintenance
DRUG: AHCT intensification, Tec-Dara consolidation, Tec-Dara maintenance
DRUG: AHCT intensification, Dara-R consolidation, Dara-R maintenance
DRUG: Dara-VRd induction

Sponsor

University of Alabama at Birmingham

Collaborators

[object Object]
[object Object]
[object Object]